5.Bradshaw CS, AN Morton, J Hocking, SM Garland, MB Morris, LM Moss, LB Horvath, I Kuzevska and CK Fairley. (2006). High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 193:1478-86.

6.Hemmerling A, W Harrison, A Schroeder, J Park, A Korn, S Shiboski and CR Cohen. (2009). Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis. Sex Transm Dis 36:564-9.

7.Paavonen J and RC Brunham. (2018). Bacterial Vaginosis and Desquamative Inflammatory Vaginitis. N Engl J Med 379:2246-2254.

8.Klatt NR, R Cheu, K Birse, AS Zevin, M Perner, L Noel-Romas, A Grobler, G Westmacott, IY Xie, J Butler, L Mansoor, LR McKinnon, JS Passmore, Q Abdool Karim, SS Abdool Karim and AD Burgener. (2017). Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science 356:938-945.

9.Mehta O, TS Ghosh, A Kothidar, MR Gowtham, R Mitra, P Kshetrapal, N Wadhwa, R Thiruvengadam, GA-Is group, GB Nair, S Bhatnagar and B Das. (2020). Vaginal Microbiome of Pregnant Indian Women: Insights into the Genome of Dominant Lactobacillus Species. Microb Ecol 80:487-499.

作者｜赵婧

审校｜617

本文仅代表作者个人观点，与本网无关。